News

Lung cancer screening strategy a work in progress

Publish date: February 5, 2014

 

EXPERT ANALYSIS FROM AN AACR-IASLC JOINT CONFERENCE

Dr. Aberle said that she had no relevant financial conflicts to disclose.

dbrunk@frontlinemedcom.com

Pages

Recommended Reading

Bupropion-varenicline combo gave harder kick to smoking habits
MDedge Hematology and Oncology
Pediatricians, cancer groups ask regulators to help cut tobacco use
MDedge Hematology and Oncology
VIDEO: What's next for lung cancer detection and treatment?
MDedge Hematology and Oncology
Surgeon General report links smoking to diseases beyond cancer
MDedge Hematology and Oncology
Imaging, biomarkers, clinical findings guide approach to indeterminate pulmonary nodules
MDedge Hematology and Oncology
The role of immunotherapy in NSCLC to expand
MDedge Hematology and Oncology
Anti-PD-L1 therapy yielded durable responses in early NSCLC trials
MDedge Hematology and Oncology
Understanding the experience of living with non–small-cell lung cancer (NSCLC): a qualitative study
MDedge Hematology and Oncology
Afatinib in metastatic NSCLC with mutations
MDedge Hematology and Oncology
Synthetic lethality: beating cancer at its own game
MDedge Hematology and Oncology